Physician profile
Rina Awan
NPI 1124226899
$2,566.82
in general payments reported to CMS, 2019-2025
22 companies · $584 in 2025
The $584 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.76 · 2020: $13.68 · 2021: $185 · 2022: $508 · 2023: $754 · 2024: $440 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,756 · Education: $21.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,756.18 |
| Education | $21.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $808.19 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $325.91 | 2022-2025 | Tezspire, Fasenra, Breztri |
| Actelion Pharmaceuticals US, INC. | $240.11 | 2022-2024 | Uptravi, Opsumit |
| Insmed, INC. | $214.43 | 2021-2025 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $168.20 | 2023-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.45 | 2021-2023 | Ofev |
| Electromed, INC. | $129.75 | 2021-2024 | Smartvest |
| Inari Medical, INC. | $115.84 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shionogi INC | $106.39 | 2022-2024 | Fetroja |
| Inogen, INC. | $63.11 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Tactile Systems Technology INC | $51.48 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Genentech USA, INC. | $30.96 | 2019-2022 | |
| Amgen INC. | $23.85 | 2023 | Tezspire |
| Lilly USA, LLC | $20.34 | 2025 | Zepbound |
| Melinta Therapeutics, LLC | $20.31 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $19.78 | 2023 | Quviviq |
| Resmed Corp | $19.38 | 2024 | |
| Currax Pharmaceuticals LLC | $17.10 | 2023 | Contrave |
| Philips North America LLC | $15.60 | 2024 | (Ak6) Vest Therapy |
| Allergan, INC. | $15.45 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.34 | 2021 | |
| Merck Sharp & Dohme LLC | $11.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rina Awan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.